Sung-jun Han joins as CEO

Acquired KRW 6 billion investment from Dx&Vx for increase in paid-in capital

Completed phase 1 clinical trials of a new drug for age-related macular degeneration.

Completed phase 1 clinical trials of a new drug for dry eye syndrome

CEO was awarded the Minister of Science and ICT Award for Persons of Distinguished Service to Science and Technology.

Procured a project grant for Global Clinical Trial Outbound from the Ministry of Health and Welfare.

Procured a project grant for Pharmaceutical Industry Full-Cycle Global Expansion from the Ministry of Health and Welfare

Phase II clinical trial approved for a new anti-AIDS drug (AVI-CO-004) from the Ministry of Health (Vietnam).

Acquired Series C investment of KRW 10.6 billion.

Phase II clinical trial approved for a new anti-AIDS drug (AVI-CO-004) from the Ministry of Health (Vietnam).

IND approval for phase I clinical trials of a new drug for dry eye disease from the Ministry of Food and Drug Safety.

Phase I clinical trials approved for a new age-related macular degeneration drug in Australia.

Received an IND approval for phase 1 clinical trials of a new age-related macular degeneration drug from the Ministry of Food and Drug Safety.

Acquired Series B investment of KRW 10 billion.

IND approval for phase II clinical trials of a new anti-AIDS drug from the Ministry of Food and Drug Safety.

Awarded the Bio Technology Innovation Award in “New Drug Development” among leading companies in Korea. - Money Today

Completed phase I clinical trials of a new anti-AIDS drug.

Awarded for the Best Patent of the Year in Korea – Hankook Ilbo

Acquired Series A investment of KRW 6 billion from institutional investors.

New anti-AIDS drug designated as an orphan drug in the development stage by the Ministry of Food and Drug Safety.

Began non-clinical R&D for a new drug candidate for AIDS.

Procured a 2-year project grant for the Pre-Clinical Research Project for the Development of New and Orphan Drugs from the Ministry of Health and Welfare.

Procured a project grant for the Global Next-Generation New Anti-AIDS Drug Candidate Development Project from the Ministry of Education, Science and Technology.

Procured a 5-year project grant for the Future-Based Technology Project from the Ministry of Science and ICT.

Registered as a research institute.

Awarded the grand prize for Research in Health Industry at the Health Industry Technologies Exposition Korea hosted by the Ministry of Health and Welfare.

Certified as a venture business by the Small and Medium Business Administration.

Founded Avixgen Co., Ltd.